<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> is a clonal disease of stem cell characterized by peripheral blood <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> with <z:e sem="disease" ids="C0151773" disease_type="Disease or Syndrome" abbrv="">hypocellular bone marrow</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In most cases acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is an autoimmune, T-cell mediated disease (hematopoiesis is mediated by a population of CD8+ T-cells which produce inhibitory cytokines - TNF-alpha, IFN-gamma, IL-6 which suppress hematopoiesis by affecting the mitotic cycle and cell killing by inducing <z:mpath ids='MPATH_3'>apoptosis</z:mpath>) </plain></SENT>
<SENT sid="2" pm="."><plain>In some cases radiation, medical drugs and chemicals, viruses induce <z:mpath ids='MPATH_63'>depletion</z:mpath> of hematopoietic stem cells by direct toxicity; <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune diseases</z:e> induce complex immune reactions leading to <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Symptoms and signs are represented by <z:mp ids='MP_0002899'>fatigue</z:mp>, <z:hpo ids='HP_0000980'>pallor</z:hpo> induces by <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> induce by <z:hpo ids='HP_0001875'>neutropenia</z:hpo>, and <z:mp ids='MP_0001914'>bleedings</z:mp> induce by <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In peripheral blood is present <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and bone marrow are characterized by hypocellularity, <z:mpath ids='MPATH_145'>fat cells hyperplasia</z:mpath>, residual <z:hpo ids='HP_0100827'>lymphocytosis</z:hpo>, <z:e sem="disease" ids="C0085663" disease_type="Disease or Syndrome" abbrv="">plasmocytosis</z:e> and <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The aim of this study was to establish the correlation between etiology, pathophysiology, bone marrow histology and negative prognosis factors at 16 patients with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (seven with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and nine with moderate <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>) hospitalized in Clinic of Hematology from Craiova between 2003-2008 </plain></SENT>
<SENT sid="6" pm="."><plain>Eight cases presented idiopathic <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and eight cases secondary <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (two of them with pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath>) </plain></SENT>
<SENT sid="7" pm="."><plain>Conclusions: The unfavorable evolution, correlated with etiology and pathophysiology, had been seen at the patients with severe idiopathic <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and severe secondary <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> associated with <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and <z:chebi fb="57" ids="24852">insecticides</z:chebi> exposure </plain></SENT>
<SENT sid="8" pm="."><plain>Pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> was associated in our study with B19 <z:e sem="disease" ids="C0205882" disease_type="Disease or Syndrome" abbrv="">parvovirus infection</z:e> or malignant <z:hpo ids='HP_0100522'>thymoma</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The negative prognosis factors in acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, correlated with laboratory findings and a low survival, were: severe <z:hpo ids='HP_0001875'>neutropenia</z:hpo>, platelets count less than 10 000/microL, corrected reticulocytes less than 1%, hypocellularity of bone marrow &lt;10%, persistence of <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> at 30 days after initiating therapy </plain></SENT>
</text></document>